InfezMed - InfezMed - Selected articles

Selected articles

Several new articles are included in this section that we considered interesting among those published in the literature or suggested by colleagues interacting with the website. All selected articles are free access online.

Urinary tract infections (17)

Skin and soft tissues infections (19)

Respiratory tract infections (12)

Intraabdominal infections (13)

HIV infections (14)

Hepatitis (20)

Fungal infections (14)

Bone and joints infections (12)

Bacterial resistance (16)

Antibacterial therapy (16)

Current Treatment Options for Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection

Robert C. Moellering, Jr.

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

Alex Soriano, Francesc Marco, Jose A. Martınez, Elena Pisos, Manel Almela, Veselka P. Dimova, Dolores Alamo, Mar Ortega, Josefina Lopez, and Josep Mensa

The Maxwell Finland Lecture: For the Duration-Rational Antibiotic Administration in an Era of Antimicrobial Resistance and Clostridium difficile

Louis B. Rice

Skin and Soft-Tissue Infections Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus

Martin E. Stryjewski and Henry F. Chambers

Association of Nasopharyngeal Bacterial Colonization during Upper Respiratory Tract Infection and the Development of Acute Otitis Media

Krystal Revai, Dheeresh Mamidi, and Tasnee Chonmaitree

Daptomycin: a new treatment for insidious infections due to gram-positive pathogens

Philippe Cottagnoud

Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus

J. Rodrıguez-Bana, A. B. Millana, M. A. Domınguez, C. Borraz, M. P. Gonzalez, B. Almirante, E. Cercenado, B. Padilla, M. Pujol, on behalf of GEIH/GEMARA/REIPI

Nitazoxanide versus Vancomycin in Clostridium difficile Infection: A Randomized, Double-Blind Study

D. M. Musher, N. Logan, A. M. Bressler, D. P. Johnson, J.F. Rossigno

Methicillin-Susceptible Staphylococcus aureus in Skin and Soft Tissue Infections, Northern Italy

M. Tinelli, M. Monaco, M. Vimercati, A. Ceraminiello, A. Pantosti

Methicillin-Susceptible Staphylococcus aureus in Skin and Soft Tissue Infections, Northern Italy

M. Tinelli, M. Monaco, M. Vimercati, A. Ceraminiello, A. Pantosti

Methicillin-Susceptible Staphylococcus aureus in Skin and Soft Tissue Infections, Northern Italy

M. Tinelli, M. Monaco, M. Vimercati, A. Ceraminiello, A. Pantosti

Past, Present, and Future of Japanese Encephalitis

T. E. Erlanger, S. Weiss, J. Keiser, J. Utzinger, K. Wiedenmayer

Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic

S. E. Cosgrove, G. A. Vigliani, M. Campion, V. G. Fowler Jr., E. Abrutyn, G. R. Corey, D. P. Levine, M. E. Rupp, H. F. Chambers, A. W. Karchmer, H. W. Boucher

Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: A meta-analysis of randomized controlled trials

M. E. Falagas, I. K. Kotsantis, E. K. Vouloumanou, P.I. Rafailidis

Health Care-Associated Clostridium difficile Infection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study

D. Gravel, M. Miller, A. Simor, G. Taylor, M. Gardam, A. McGeer, J. Hutchinson, D. Moore, S. Kelly, D. Boyd, M. Mulvey, and the Canadian Nosocomial Infection Surveillance Programa

Daptomycin in bone and joint infections: a review of the literature

Rice DAK, Mendez-Vigo L.

The treatment of diabetic foot infections: focus on ertapenem

Edmonds M.

The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients

Amorosa VK, Slim J, Mounzer K, Bruno C, Hoffman-Terry M, Dorey-Stein Z, Ferrara T, Kostman JR, Lo Re V

Summary of CDC consultation to address social determinants of health for prevention of disparities in HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis. December 9-10, 2008

Sharpe TT, Harrison KM, Dean HD.

Summary of CDC consultation to address social determinants of health for prevention of disparities in HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis. December 9-10, 2008

Sharpe TT, Harrison KM, Dean HD.

Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B.

Suh DJ, Um SH, Herrmann E, Kim JH, Lee YS, Lee HJ, Lee MS, Lee YJ, Bao W, Lopez P, Lee HC, Avila C, Zeuzem S.

Clinical management of hepatitis B virus infection correlated with liver transplantation

Zhang J, Zhou L, Zheng SS.

A new insight into hepatitis C vaccine developmen

Yu CI, Chiang BL.

Trimethoprim-Sulfamethoxazole or Clindamycin for Community-Associated MRSA (CA-MRSA) Skin Infections

Frei CR, Miller ML, Lewis JS 2nd, Lawson KA, Hunter JM, Oramasionwu CU, Talbert RL.

nteraction of staphylococci with bone

Wright JA, Nair SP.

Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis? A prospective tria

Faesch S, Cojocaru B, Hennequin C, Pannier S, Glorion C, Lacour B, Chéron G.

Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial

Turner D, Little P, Raftery J, Turner S, Smith H, Rumsby K, Mullee M; UTIS group.

Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study

Little P, Merriman R, Turner S, Rumsby K, Warner G, Lowes JA, Smith H, Hawke C, Leydon G, Mullee M, Moore MV.

Fluoroquinolone resistance and Clostridium difficile, Germany

Zaiss NH, Witte W, Nübel U.

Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008

Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P.